3,4 Important safety information: Retatrutide is an experimental medication
DISCOVERY OF THE AMYLIN-ANALOGUE CAGRILINTIDE Amylin is a 37-amino acid peptide that is co-released with insulin from beta cells in the pancreas
This medication, initially developed for treating type 2 diabetes, has gained attention for its effectiveness in promoting weight loss
Taken together, weight loss induced bone loss represents a clinical challenge that is likely to be more prevalent as anti-obesity treatments become more widely available
When theres desperation and money to be made, con men are not far behind
human epidermal growth factor receptor 2-positive metastases, for example, show higher expression of GLUT-1 and breast cancer resistance protein (BCRP) compared to other subtypes [175]